Pharmacological options for the treatment of chronic migraine pain

被引：3
作者：
Urits, Ivan [1 ]
Gress, Kyle [2 ]
Charipova, Karina [2 ]
Zamarripa, Alec M. [3 ]
Patel, Parth M. [3 ]
Lassiter, Grace [2 ]
Jung, Jai Won [2 ]
Kaye, Alan D. [4 ]
Viswanath, Omar [3 ,4 ,5 ,6 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA
[2] Georgetown Univ, Sch Med, Washington, DC USA
[3] Univ Arizona, Dept Anesthesiol, Coll Med Phoenix, Phoenix, AZ USA
[4] Louisiana State Univ Hlth Shreveport, Dept Anesthesiol, Shreveport, LA USA
[5] Creighton Univ, Sch Med, Dept Anesthesiol, Omaha, NE USA
[6] Valley Pain Consultants Envision Phys Serv, Phoenix, AZ USA
来源：
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY | 2020年 / 34卷 / 03期
关键词：
migraine; preventive therapy; chronic pain; pharmacology; therapeutics; TOXIN TYPE-A; QUALITY STANDARDS SUBCOMMITTEE; LONG-TERM SAFETY; DOUBLE-BLIND; PREVENTIVE TREATMENT; PROPHYLACTIC TREATMENT; ANTINOCICEPTIVE ACTION; CENTRAL SENSITIZATION; ANTIEPILEPTIC DRUGS; ENERGY-METABOLISM;
D O I：
10.1016/j.bpa.2020.08.002
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Migraine is a debilitating neurological condition with symptoms typically consisting of unilateral and pulsating headache, sensitivity to sensory stimuli, nausea, and vomiting. The World Health Organization (WHO) reports that migraine is the third most prevalent medical disorder and second most disabling neurological condition in the world. There are several options for preventive migraine treatments that include, but are not limited to, anticonvulsants, antidepressants, beta blockers, calcium channel blockers, botulinum toxins, NSAIDs, riboflavin, and magnesium. Patients may also benefit from adjunct nonpharmacological options in the comprehensive prevention of migraines, such as cognitive behavior therapy, relaxation therapies, biofeedback, lifestyle guidance, and education. Preventative therapies are an essential component of the overall approach to the pharmacological treatment of migraine. Comparative studies of newer therapies are needed to help patients receive the best treatment option for chronic migraine pain. (C) 2020 Published by Elsevier Ltd.
引用
收藏
页码：383 / 407
页数：25
相关论文
共 50 条
  • [41] The pathophysiological and pharmacological basis of current drug treatment of migraine headache
    Reddy, Doodipala Samba
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (03) : 271 - 288
  • [42] A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches
    Peck, Jacquelin
    Urits, Ivan
    Zeien, Justin
    Hoebee, Shelby
    Mousa, Mohammad
    Alattar, Hamed
    Kaye, Alan D.
    Viswanath, Omar
    CURRENT PAIN AND HEADACHE REPORTS, 2020, 24 (05)
  • [43] Sodium channel antagonists for the treatment of migraine
    Chiossi, Lorenza
    Negro, Andrea
    Capi, Matilde
    Lionetto, Luana
    Martelletti, Paolo
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (12) : 1697 - 1706
  • [44] Chronic migraine-classification, characteristics and treatment
    Diener, Hans-Christoph
    Dodick, David W.
    Goadsby, Peter J.
    Lipton, Richard B.
    Olesen, Jes
    Silberstein, Stephen D.
    NATURE REVIEWS NEUROLOGY, 2012, 8 (03) : 162 - 171
  • [45] OnabotulinumtoxinA for Treatment of Chronic Migraine: The Unblinding Problem
    Solomon, Seymour
    HEADACHE, 2013, 53 (05): : 824 - 826
  • [46] Pharmacological pain management in chronic pancreatitis
    Olesen, Soren S.
    Juel, Jacob
    Graversen, Carina
    Kolesnikov, Yuri
    Wilder-Smith, Oliver H. G.
    Drewes, Asbjorn M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (42) : 7292 - 7301
  • [47] Chronic maladaptive pain in cats: A review of current and future drug treatment options
    Adrian, Derek
    Papich, Mark
    Baynes, Ron
    Murrell, Jo
    Lascelles, B. Duncan X.
    VETERINARY JOURNAL, 2017, 230 : 52 - 61
  • [48] Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
    de Vries, Tessa
    Villalon, Carlos M.
    MaassenVanDenBrink, Antoinette
    PHARMACOLOGY & THERAPEUTICS, 2020, 211
  • [49] CHRONIC PAROXYSMAL HEMICRANIA COEXISTING WITH MIGRAINE - DIFFERENTIAL RESPONSE TO PHARMACOLOGICAL TREATMENT
    PAREJA, J
    PAREJA, J
    HEADACHE, 1992, 32 (02): : 77 - 78
  • [50] Menstrual migraine: treatment options
    Newman, L. C.
    Yugrakh, M. S.
    NEUROLOGICAL SCIENCES, 2014, 35 : S57 - S60
12345